Navigation Links
HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2008 Out-of-Pocket Drug Costs
Date:12/3/2007

COLUMBUS, Ohio, Dec. 3 /PRNewswire/ -- Seniors who take a close look at the Part D drug coverage offered by Medicare Advantage plans may reap handsome savings next year. Many Medicare HMO and PPO plans will continue to offer $0 monthly premiums and $0 deductibles with either complete or partial coverage throughout the "gap" or "donut hole" (when beneficiaries pay 100% of their drug bills until reaching $4,050 in out-of-pocket costs). HealthMetrix Research Inc. screened over 400 such Medicare Advantage plans to identify which ones offer the best Part D drug benefits in 2008. The findings are based solely on estimated member out-of-pocket costs and do not compare drug formularies.

According to HealthMetrix Research Inc. and MedicareNewsWatch.com president Alan Mittermaier, "The findings are favorable for seniors in most areas of the country who can enroll in $0 premium Medicare Advantage-Part D plans. For 2008, there are no $0 premium drug-only Part D plans available except for low-income seniors who qualify for premium subsidies. Beneficiaries currently enrolled in drug-only plans will see 17% premium increases on average effective January 1st. That is on top of premium increases for most Medigap supplemental insurance coverage. Seniors who are willing to bundle their Medicare coverage by enrolling in a Medicare HMO or PPO plan can realize considerable savings in annual medical and drug expenses even with pre-existing medical conditions. The strategy and savings are similar to bundling auto, property and life insurance policies with a single insurer."

Alan Mittermaier also notes that "what may not register with all seniors is that the same Medicare regulatory protections apply to enrollees in both drug-only and Medicare Advantage Part D plans with respect to required drug formulary lists and the rules for switching or dropping drugs. The reality is that drug-only Part D plan sponsors will manage their drug benefits just as aggressively as Medicar
'/>"/>

SOURCE HealthMetrix Research Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. HealthMetrix Research Selects 2008 Medicare Advantage Plans for Best Overall Benefit Value
2. Stanford researchers find culprit in aging muscles that heal poorly
3. Children of depressed moms do better when dad is involved, SLU researcher finds
4. UCLA researchers identify markers that may predict diabetes in still-healthy people
5. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
6. New research shows how chronic stress worsens neurodegenerative disease course
7. New research explores newborn in-hospital weight loss
8. Research may unlock mystery of autisms origin in the brain
9. Bipolar disorder relapses halved by Melbourne researchers
10. HIVs impact in Zimbabwe explored in new research
11. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2
...rgery in obese patients, especially in laproscopic...y catheter and an // arterial line, says a study ... Morbid obesity is a condition that has a ge...ts in controlling the obesity. One of the mo...
...placing lost sensory hair cells in the inner ear m...mals, say a recent study// published in Nature Med... viral vector found in a developmental regulatory ...row as the differentiated non-sensory cells of the...
...e researchers at Harvard School of Public Health h...duce the risk of having multiple// sclerosis (MS) ...amin D supplement had a 40% less chance of develop...here is no cure for this disease but modern day tr...
... is possible to reduce eye infections like keratit... for longer hours, reports British Journal// of Op...e on contact lens wearers for daily wear or extend...earers for a 12-month hospital based study and had...
...alysis of medical records of liver cancer patients...ics are stand a three fold risk // of developing l... After taking other factors into account, such as ...hich is a known risk factor for liver cancer, may ...
... the 83rd General Session of the International Ass..., Japanese scientists have presented the results o...good for people suffering from bad breath. Or...had sugar-free more and natural form of yogurt for...
Other Medicine News:
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6William Dwyer Named to PerfectServe Advisory Board 57496 1William Dwyer Named to PerfectServe Advisory Board 57496 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 1Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 3Cyberonics to Present at Maxim Group Growth Conference 57492 1Cyberonics to Present at Maxim Group Growth Conference 57492 2
... Reported Safety & Tolerability Profile,in Sub...CHICAGO, June 25 /PRNewswire-FirstCall/ -- Phase I...of the American Diabetes,Association demonstrated ...dase-4 (DPP-4) in development by Bristol-Myers,Squ...), in,combination with metformin, exhibited a stat...
...-Funded Immune Globulin Study Uncovers Sample,Mani...PRNewswire-USNewswire/ -- An analysis,released tod...,study ruling out a link between autism and Rh imm...ained the mercury-based,preservative thimerosal. B...red manipulation of the study sample, so that,earl...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 2Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 3
QuikCoag CaCl2
QuikCoag Control 2
..., compact design. Using optical light scatter for ...YN 3200 meets the needs of today's laboratory. The...-part differential analysis, automated sample hand...y. The system combines proven Multi-Angle Polarize...
Perclose A-T Suture-Mediated Closure
Medicine Products: